Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model.
about
Computer simulations of the signalling network in FLT3 +-acute myeloid leukaemia - indications for an optimal dosage of inhibitors against FLT3 and CDK6.Design, Synthesis and Biological Activity Evaluation of S-Substituted 1-5-Mercapto-1,2,4-Triazole Derivatives as Antiproliferative Agents in Colorectal CancerHow Do We "Validate" a QSP Model?
P2860
Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Clinical responses to ERK inhi ...... d using a computational model.
@ast
Clinical responses to ERK inhi ...... d using a computational model.
@en
type
label
Clinical responses to ERK inhi ...... d using a computational model.
@ast
Clinical responses to ERK inhi ...... d using a computational model.
@en
prefLabel
Clinical responses to ERK inhi ...... d using a computational model.
@ast
Clinical responses to ERK inhi ...... d using a computational model.
@en
P2093
P2860
P1476
Clinical responses to ERK inhi ...... d using a computational model.
@en
P2093
Christine Orr
Daniel C Kirouac
Gabriele Schaefer
Jocelyn Chan
John Moffat
Kapil Gadkar
Lichuan Liu
Mark Merchant
Saroja Ramanujan
Shih-Min A Huang
P2860
P2888
P356
10.1038/S41540-017-0016-1
P577
2017-06-02T00:00:00Z
P6179
1085747478